low-grade-glioma

Documents about low-grade-glioma

• HyperSpectral Imaging in Low Grade Glioma#1088830ClinicalTrials.gov
• Surgical Management of Low Grade Glioma#1295587ClinicalTrials.gov
• Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma#866500ClinicalTrials.gov
• CEST in Low-grade Glioma Study#1126776ClinicalTrials.gov
• A Vaccine Trial for Low Grade Gliomas#67682ClinicalTrials.gov
• Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma#1437812ClinicalTrials.gov
• Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)#915818ClinicalTrials.gov
• Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma#968815ClinicalTrials.gov
• FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery#848773ClinicalTrials.gov
• Fluorescence Spectroscopy Guided Surgery#1140865ClinicalTrials.gov
• Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype#383567ClinicalTrials.gov
• Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared#1172328ClinicalTrials.gov
• Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib#1293978ClinicalTrials.gov
• A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma#825823ClinicalTrials.gov
• Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery#1008614ClinicalTrials.gov
• Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas#839310ClinicalTrials.gov
• Practical management of BRAF inhibitors in glioma: toxicity and resistance#669754Europe PMC
• A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors#1171074ClinicalTrials.gov
• Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas#1125613ClinicalTrials.gov
• FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration#905328ClinicalTrials.gov
• Proton Radiation Therapy for Gliomas#869788ClinicalTrials.gov
• A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas#1057835ClinicalTrials.gov
• Trial in Low Grade Glioma Patients: Wait or Treat#1444429ClinicalTrials.gov
• Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy#849967ClinicalTrials.gov
• Study of Tissue and Blood Samples From Patients With Low-Grade Glioma#966435ClinicalTrials.gov
• Nivolumab for Recurrent or Progressive IDH Mutant Gliomas#1496083ClinicalTrials.gov
• Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma#1349599ClinicalTrials.gov
• FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma#875954ClinicalTrials.gov
• Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma#1045190ClinicalTrials.gov
• Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study#1101854ClinicalTrials.gov
• Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker#1184160ClinicalTrials.gov
• Effects of Exercise on Cognitive Function in Glioma Patients#1007924ClinicalTrials.gov
• Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas#840719ClinicalTrials.gov
• Window of Opportunity Study of DSP-0390 in Gliomas#902245ClinicalTrials.gov
• fMRI Study of Functional Reorganization in Glioma Patients#834272ClinicalTrials.gov
• Neurocognitive Assessment CNSL and LGG#870978ClinicalTrials.gov
• Niraparib In Recurrent IDH 1/2 Gliomas#835235ClinicalTrials.gov
• Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas#1243660ClinicalTrials.gov
• MR Textural Analysis in Low Grade Gliomas#1293193ClinicalTrials.gov
• Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations#1183186ClinicalTrials.gov
• Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas#890765ClinicalTrials.gov
• Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma#1262246ClinicalTrials.gov
• Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area#918380ClinicalTrials.gov
• Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery#844143ClinicalTrials.gov
• A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas#898649ClinicalTrials.gov
• SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue#901023ClinicalTrials.gov
• Functional Outcome Following Treatment of Lower-Grade Gliomas#185262GUPEA
• Study of AG-120 and AG-881 in Subjects With Low Grade Glioma#1111560ClinicalTrials.gov
• ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas#154667ClinicalTrials.gov
• Segmentation-Free Preoperative 3D MRI Classification of Low-Grade Versus High-Grade Glioma Using Task-Oriented Neural Architecture Search.#315462NCBI PubMed Central